On the armamentarium to overcome these challenges, etoposide (topoisomerase II inhibitor) has been a widely used chemotherapeutic agent to facilitate the collection of CD34+ stem cells in patients with various hematologic diseases. The gene discussed is CD34; the disease is hematologic disorder.